Screen time at age 1 year tied to worse later developmental performance

by Lori SolomonIncreased TV/DVD screen time at 1 and 2 years of age negatively affects developmental performance at 2 and 3 years of age, according to a study published online Sept. 18 inJAMA Pe

Updated on: January 21,2024

Screen time at age 1 year tied to worse later developmental performance

by Lori SolomonIncreased TV/DVD screen time at 1 and 2 years of age negatively affects developmental performance at 2 and 3 years of age, according to a study published online Sept. 18 inJAMA Pe

Updated on:January 21,2024

A 'feeling' for dementia?

by German Center for Neurodegenerative DiseasesCredit: CC0 Public DomainA research team led by the German Center for Neurodegenerative Diseases (DZNE) concludes that personal perception can be an

Updated on: May 26,2024

A 'feeling' for dementia?

by German Center for Neurodegenerative DiseasesCredit: CC0 Public DomainA research team led by the German Center for Neurodegenerative Diseases (DZNE) concludes that personal perception can be an

Updated on:May 26,2024

Insight into cells' 'self-eating' process could pave the way for new dementia treatments

by University of PlymouthThe autophagy system in cells. Green and yellow dots: autophagosomes; red dots: autophagosomes fused with lysosomes. Credit: University of PlymouthCells regularly go thro

Updated on: May 26,2024

Insight into cells' 'self-eating' process could pave the way for new dementia treatments

by University of PlymouthThe autophagy system in cells. Green and yellow dots: autophagosomes; red dots: autophagosomes fused with lysosomes. Credit: University of PlymouthCells regularly go thro

Updated on:May 26,2024

Study reveals molecular mechanism behind multiple sclerosis and other autoimmune diseases

by Kevin Dennehy,Yale UniversityCredit: Unsplash/CC0 Public DomainMore than two decades ago, a research team in the lab of David Hafler, a Yale researcher who at the time was at Harvard, discove

Updated on: September 10,2024

Study reveals molecular mechanism behind multiple sclerosis and other autoimmune diseases

by Kevin Dennehy,Yale UniversityCredit: Unsplash/CC0 Public DomainMore than two decades ago, a research team in the lab of David Hafler, a Yale researcher who at the time was at Harvard, discove

Updated on:September 10,2024

What’s that smell — and how’d you know?

Updated on: October 22,2024

What’s that smell — and how’d you know?

Updated on:October 22,2024

Trial begins of nasal vaccine for Alzheimer's disease

(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.This is a "remarkable milestone,

Updated on: April 02,2024

Trial begins of nasal vaccine for Alzheimer's disease

(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.This is a "remarkable milestone,

Updated on:April 02,2024

Deep neural networks show promise as models of human hearing

byMassachusetts Institute of Technology(A) Regression analysis (voxelwise modeling). (B) Representational Similarity Analysis. Credit:bioRxiv: DOI: 10.1101/2022.09.06.506680Computational m

Updated on: January 02,2024

Deep neural networks show promise as models of human hearing

byMassachusetts Institute of Technology(A) Regression analysis (voxelwise modeling). (B) Representational Similarity Analysis. Credit:bioRxiv: DOI: 10.1101/2022.09.06.506680Computational m

Updated on:January 02,2024

Atogepant prevents migraine in adults

Atogepant appears to be effective and well tolerated for the preventive treatment of migraine, according to a study published online June 8 inJAMA Network Open.Richard B. Lipton, M.D., from Albe

Updated on: January 21,2024

Atogepant prevents migraine in adults

Atogepant appears to be effective and well tolerated for the preventive treatment of migraine, according to a study published online June 8 inJAMA Network Open.Richard B. Lipton, M.D., from Albe

Updated on:January 21,2024

Developmental crossroads in the brain: How proteins direct nerve cell precursors to turn into specialized neurons

byMax Planck SocietyBrain functions such as motivated behavior, reward learning and decision making are enabled by inhibitory projection neurons. Researchers now show that the protein MEIS2 play

Updated on: March 27,2024

Developmental crossroads in the brain: How proteins direct nerve cell precursors to turn into specialized neurons

byMax Planck SocietyBrain functions such as motivated behavior, reward learning and decision making are enabled by inhibitory projection neurons. Researchers now show that the protein MEIS2 play

Updated on:March 27,2024

Discovery of early plasma biomarkers for Alzheimer's disease

by Institut national de la recherche scientifiqueINRS Professor Charles Ramassamy, specialist on Alzheimer's disease, doctoral student Mohamed Raâfet Ben Khedher and postdoctoral student Mohamed H

Updated on: May 28,2024

Discovery of early plasma biomarkers for Alzheimer's disease

by Institut national de la recherche scientifiqueINRS Professor Charles Ramassamy, specialist on Alzheimer's disease, doctoral student Mohamed Raâfet Ben Khedher and postdoctoral student Mohamed H

Updated on:May 28,2024

Common viruses may be triggering the onset of Alzheimer's disease

by Tufts UniversityVaricella zoster virus (VZV), which commonly causes chickenpox and shingles, activates herpes simplex virus (HSV) from dormancy in neural tissue grown in vitro, which then lead

Updated on: May 05,2024

Common viruses may be triggering the onset of Alzheimer's disease

by Tufts UniversityVaricella zoster virus (VZV), which commonly causes chickenpox and shingles, activates herpes simplex virus (HSV) from dormancy in neural tissue grown in vitro, which then lead

Updated on:May 05,2024

New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions'

by University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainTwo stories dominated Alzheimer's news this year: The FDA's approval of Leqembi, the first drug to slow progression of

Updated on: February 24,2024

New Alzheimer's drug shines light on need for assessments to head off 'a tsunami of cognitive afflictions'

by University of Southern CaliforniaCredit: Pixabay/CC0 Public DomainTwo stories dominated Alzheimer's news this year: The FDA's approval of Leqembi, the first drug to slow progression of

Updated on:February 24,2024